BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
| 3.59 Delayed Data As of Oct 21 |  +0.08 / +2.28%Today’s Change | 1.38 Today|||52-Week Range 6.29 | +4.06% Year-to-Date |
Latest BCRX News | Press Releases
No recent news for BioCryst Pharmaceuticals Inc.
Today’s Trading
| Previous close | 3.51 |
| Today’s open | 3.55 |
| Day’s range | 3.52 - 3.71 |
| Volume | 232,278 |
| Average volume (3 months) | 6,330,136 |
| Market cap | $679.8M |
Data as of 4:00pm ET, 10/21/2020
Growth & Valuation
| Earnings growth (last year) | +4.00% |
| Earnings growth (this year) | +0.85% |
| Earnings growth (next 5 years) | +19.86% |
| Revenue growth (last year) | +136.45% |
| P/E ratio | NM |
| Price/Sales | 8.17 |
| Price/Book | 15.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RDUSRadius Health Inc | 0.00 | 0.00% |
| KDMNKadmon Holdings Inc | -0.29 | -7.82% |
| AUTLAutolus Therapeutics... | +0.20 | +1.73% |
| VBIVVBI Vaccines Inc | -0.08 | -3.07% |
Data as of 4:00pm ET, 10/21/2020
Financials
| Next reporting date | November 10, 2020 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $48.8M |
| Annual profit (last year) | -$108.9M |
| Net profit margin | -222.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
